Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v2-FR
Language French French
Date Updated 2022-05-25 2022-04-29
Drug Identification Number 02390841 02390841
Brand name SANDOZ PREGABALIN SANDOZ PREGABALIN
Common or Proper name PREGABALIN PREGABALIN
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients PREGABALIN PREGABALIN
Strength(s) 150MG 150MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 500HGC BO 500HGC BO
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-04-28 2022-04-28
Estimated end date 2022-05-20 2022-05-27
Actual end date 2022-05-24
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments